Literature DB >> 18756552

Site-specific chemical modification of proteins with a prelabelled cysteine tag using the artificially split Mxe GyrA intein.

Thomas Kurpiers1, Henning D Mootz.   

Abstract

The selective modification of proteins with a synthetic probe is of central interest for many aspects of protein chemistry. We have recently reported a new approach in which a short cysteine-containing tag (CysTag) fused to one part of a split intein is first modified with a sulfhydryl-reactive probe. In a second step, protein trans-splicing is used to link the labelled CysTag to a target protein that has been expressed in fusion with the complementary split intein fragment. Here, we present the generation and biochemical characterisation of the artificially split Mycobacterium xenopi GyrA intein. We show that this split intein is active without a renaturation step and that it provides a significant improvement for the CysTag protein-labelling approach in terms of product yields and target protein tolerance. Two proteins with multiple cysteine residues, human growth hormone and a multidomain nonribosomal peptide synthetase, were site-specifically modified with high yields. Our approach combines the benefits of the plethora of commercially available cysteine-reactive probes with a straightforward route for their site-specific incorporation even into complex and cysteine-rich proteins.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18756552     DOI: 10.1002/cbic.200800319

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


  11 in total

1.  In-cell fluorescence activation and labeling of proteins mediated by FRET-quenched split inteins.

Authors:  Radhika Borra; Dezheng Dong; Ahmed Y Elnagar; Getachew A Woldemariam; Julio A Camarero
Journal:  J Am Chem Soc       Date:  2012-03-28       Impact factor: 15.419

2.  Unprecedented rates and efficiencies revealed for new natural split inteins from metagenomic sources.

Authors:  Patricia Carvajal-Vallejos; Roser Pallissé; Henning D Mootz; Stefan R Schmidt
Journal:  J Biol Chem       Date:  2012-06-28       Impact factor: 5.157

3.  A mesophilic cysteine-less split intein for protein trans-splicing applications under oxidizing conditions.

Authors:  Maniraj Bhagawati; Tobias M E Terhorst; Friederike Füsser; Simon Hoffmann; Tim Pasch; Shmuel Pietrokovski; Henning D Mootz
Journal:  Proc Natl Acad Sci U S A       Date:  2019-10-14       Impact factor: 11.205

4.  Protein C-terminal labeling and biotinylation using synthetic peptide and split-intein.

Authors:  Gerrit Volkmann; Xiang-Qin Liu
Journal:  PLoS One       Date:  2009-12-21       Impact factor: 3.240

Review 5.  Recent progress in intein research: from mechanism to directed evolution and applications.

Authors:  Gerrit Volkmann; Henning D Mootz
Journal:  Cell Mol Life Sci       Date:  2012-08-28       Impact factor: 9.261

6.  Photomodulation of protein trans-splicing through backbone photocaging of the DnaE split intein.

Authors:  Luis Berrade; Youngeun Kwon; Julio A Camarero
Journal:  Chembiochem       Date:  2010-07-05       Impact factor: 3.164

7.  An Unprecedented Combination of Serine and Cysteine Nucleophiles in a Split Intein with an Atypical Split Site.

Authors:  Anne-Lena Bachmann; Henning D Mootz
Journal:  J Biol Chem       Date:  2015-10-09       Impact factor: 5.157

8.  Protein Chemical Modification Inside Living Cells Using Split Inteins.

Authors:  Radhika Borra; Julio A Camarero
Journal:  Methods Mol Biol       Date:  2017

9.  Trans-spliced Cas9 allows cleavage of HBB and CCR5 genes in human cells using compact expression cassettes.

Authors:  Eli J Fine; Caleb M Appleton; Douglas E White; Matthew T Brown; Harshavardhan Deshmukh; Melissa L Kemp; Gang Bao
Journal:  Sci Rep       Date:  2015-07-01       Impact factor: 4.379

10.  SPLICEFINDER - a fast and easy screening method for active protein trans-splicing positions.

Authors:  Joachim Zettler; Simone Eppmann; Alena Busche; Dina Dikovskaya; Volker Dötsch; Henning D Mootz; Tim Sonntag
Journal:  PLoS One       Date:  2013-09-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.